# Boston Scientific to acquire SoniVie Ltd.

Boston Scientific has agreed to acquire SoniVie Ltd., a developer of the TIVUS Intravascular Ultrasound System for renal denervation therapy to treat hypertension. The deal expands Boston Scientific's interventional cardiology portfolio.

- Type: Acquisition
- Announced: 2025-03-03
- Where: United States
- Value: $600.0M
- Status: announced
- Products: TIVUS Intravascular Ultrasound System, renal denervation therapy
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [SoniVie](https://endata.com/companies/83271.md) (target)

## Sources

- [sonivie.com](https://sonivie.com/boston-scientific-announces-agreement-to-acquire-sonivie-ltd), 2025-03-03: "We believe the addition of the differentiated, ultrasound-based TIVUS system can complement our expansive interventional portfolio with a minimally invasive therapy for patients with hypertension."
- [law360.com](https://www.law360.com/articles/2304949/boston-scientific-buying-600m-ultrasound-system-developer), 2025-03-03: "Boston Scientific Corp. announced Monday it will pay up to $540 million to acquire the 90% it doesn't already own of private medical device company SoniVie Ltd."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.